Cardiology

Deactivation of Implantable Cardioverter Defibrillators in end-of-life situations – more progress needed

Implantable Cardioverter Defibrillators are proven to reduce mortality in both patients with documented ventricular arrhythmias

Cardioverter Defibrillators

Written by Mr Paul Nolan, Clinical Lecturer & Cardiac Physiologist, Dept of Health and Nutritional Sciences, Atlantic Technological University

Introduction

For verified healthcare professionals

Log in or register for free to read this article. HPN is for healthcare professionals, so new accounts are verified by our team.

Register for free Log in

Join the conversation

Comments are open to registered members. Log in or register to share your thoughts on this article.

Log in to comment Register for free